International Conference on Palliativecare and Gerontology June 28-29, 2019 Oslo, Norway

Neurodegenerative Disorders & Dementia

\r\n Neurodegenerative disease is an umbrella term for a range of conditions which primarily affect the neurons in the human brain. This degradation can affect body movement and brain function, causing dementia (progressive or chronic decline of cognitive function that affects memory, thinking, behaviour, language, calculation, learning and emotion capacity, and should never be associated with a normal aging process) Neurodegenerative diseases have a major impact at professional, social and family level of patients and can lead to a complete inability to carry out any type of everyday activity. For example, patients may have: motors problems; breathing difficulties; cognitive problems or gradual memory loss (possibly affecting the memory of all that has been learned over a lifetime). Neurodegenerative diseases are incurable and debilitating conditions that result in progressive degeneration and / or death of nerve cells. This causes problems with movement (called ataxias), or mental functioning (called dementias).

\r\n

\r\n Dementias are responsible for the greatest burden of neurodegenerative diseases, with Alzheimer’s representing approximately 60-70% of dementia cases.

\r\n

\r\n The neurodegenerative diseases that JPND focuses on are:

\r\n

\r\n
• \r\n Alzheimer’s disease (AD) and other dementias
\r\n
• \r\n Parkinson’s disease (PD) and PD-related disorders
\r\n
• \r\n Prion disease
\r\n
• \r\n Motor neurone diseases (MND)
\r\n
• \r\n Huntington’s disease (HD)
\r\n
• \r\n Spinocerebellar ataxia (SCA)
\r\n
• \r\n Spinal muscular atrophy (SMA)
\r\n

\r\n

Recommended Sessions

Related Journals

Are you interested in